News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
106,209 Results
Type
Article (10772)
Company Profile (56)
Press Release (95381)
Multimedia
Podcasts (4)
Webinars (3)
Section
Business (29112)
Career Advice (153)
Deals (4377)
Drug Delivery (16)
Drug Development (16499)
Employer Resources (27)
FDA (2235)
Job Trends (2932)
News (51081)
Policy (4302)
Tag
Academia (722)
Accelerated approval (2)
Adcomms (5)
Allergies (13)
Alliances (8823)
ALS (21)
Alzheimer's disease (437)
Antibody-drug conjugate (ADC) (18)
Approvals (2243)
Artificial intelligence (62)
Autoimmune disease (2)
Automation (2)
Bankruptcy (22)
Best Places to Work (2764)
BIOSECURE Act (4)
Biosimilars (10)
Biotechnology (57)
Bladder cancer (17)
Brain cancer (11)
Breast cancer (74)
Cancer (510)
Cardiovascular disease (48)
Career advice (135)
Career pathing (5)
CAR-T (38)
Cell therapy (133)
Clinical research (12859)
Collaboration (225)
Compensation (95)
Complete response letters (5)
COVID-19 (523)
CRISPR (26)
C-suite (61)
Cystic fibrosis (64)
Data (595)
Depression (3)
Diabetes (43)
Diagnostics (1833)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (35)
Drug pricing (7)
Duchenne muscular dystrophy (48)
Earnings (9345)
Editorial (7)
Employer branding (4)
Employer resources (27)
Events (16133)
Executive appointments (135)
FDA (2499)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (164)
Gene editing (71)
Generative AI (2)
Gene therapy (173)
GLP-1 (96)
Government (625)
Grass and pollen (1)
Guidances (13)
Healthcare (3052)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (16)
Indications (9)
Infectious disease (556)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (9)
Intellectual property (17)
Interviews (18)
IPO (2252)
IRA (1)
Job creations (344)
Job search strategy (126)
Kidney cancer (1)
Labor market (4)
Layoffs (89)
Leadership (3)
Legal (529)
Liver cancer (10)
Lung cancer (62)
Lymphoma (42)
Machine learning (2)
Management (6)
Manufacturing (48)
MASH (6)
Medical device (804)
Medtech (805)
Mergers & acquisitions (2232)
Metabolic disorders (120)
Multiple sclerosis (19)
NASH (1)
Neurodegenerative disease (29)
Neuropsychiatric disorders (4)
Neuroscience (584)
NextGen: Class of 2025 (956)
Non-profit (824)
Now hiring (12)
Obesity (65)
Opinion (46)
Ovarian cancer (10)
Pain (11)
Pancreatic cancer (22)
Parkinson's disease (47)
Partnered (6)
Patents (36)
Patient recruitment (22)
Peanut (3)
People (9669)
Pharmaceutical (5)
Phase I (4732)
Phase II (5831)
Phase III (4204)
Pipeline (275)
Policy (10)
Postmarket research (285)
Preclinical (2022)
Press Release (21)
Prostate cancer (14)
Psychedelics (4)
Radiopharmaceuticals (32)
Rare diseases (201)
Real estate (652)
Recruiting (6)
Regulatory (3593)
Reports (9)
Research institute (842)
Resumes & cover letters (12)
Rett syndrome (5)
RNA editing (4)
RSV (3)
Schizophrenia (14)
Series A (32)
Series B (17)
Service/supplier (2)
Sickle cell disease (23)
Special edition (3)
Spinal muscular atrophy (133)
Sponsored (7)
Startups (746)
Stomach cancer (1)
Supply chain (7)
Tariffs (3)
The Weekly (4)
Vaccines (112)
Venture capitalists (8)
Weight loss (20)
Women's health (2)
Worklife (1)
Date
Last 7 days (205)
Last 30 days (496)
Last 365 days (7163)
2025 (2303)
2024 (7766)
2023 (8296)
2022 (10503)
2021 (11288)
2020 (9180)
2019 (7734)
2018 (5786)
2017 (5558)
2016 (4880)
2015 (5545)
2014 (3904)
2013 (3116)
2012 (2791)
2011 (2838)
2010 (2599)
Location
Africa (108)
Alabama (3)
Alaska (2)
Arizona (21)
Arkansas (3)
Asia (5682)
Australia (1355)
California (1336)
Canada (597)
China (105)
Colorado (41)
Connecticut (48)
Delaware (24)
Europe (14466)
Florida (120)
Georgia (12)
Idaho (5)
Illinois (54)
India (5)
Indiana (90)
Iowa (1)
Japan (46)
Kansas (8)
Kentucky (5)
Louisiana (2)
Maine (3)
Maryland (128)
Massachusetts (1234)
Michigan (52)
Minnesota (21)
Missouri (10)
Montana (5)
Nebraska (6)
Nevada (13)
New Hampshire (9)
New Jersey (289)
New Mexico (9)
New York (316)
North Carolina (174)
North Dakota (4)
Northern California (683)
Ohio (43)
Oklahoma (2)
Oregon (7)
Pennsylvania (308)
Puerto Rico (1)
Rhode Island (5)
South America (149)
South Carolina (2)
Southern California (427)
Tennessee (6)
Texas (203)
United States (4732)
Utah (80)
Virginia (38)
Washington D.C. (12)
Washington State (125)
Wisconsin (12)
106,209 Results for "cs genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CS Genetics Appoints Paul McEwan as Independent Board Director
April 28, 2025
·
2 min read
Press Releases
CS Genetics Unveils SimpleCell™: A New Era in Single-Cell Genomics
November 7, 2024
·
4 min read
Press Releases
CS Genetics Appoints Bill Colston, PhD, as Chief Executive Officer
September 25, 2024
·
3 min read
Press Releases
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
April 22, 2025
·
5 min read
Press Releases
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
March 5, 2025
·
5 min read
Press Releases
CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody
March 3, 2025
·
6 min read
Business
CS Genetics Appoints Mike Stubbington, PhD, as Vice President of Research and Development
CS Genetics, a privately held genomics-technology company, announced the appointment of Mike Stubbington, PhD, as Vice President of Research and Development.
July 11, 2023
·
3 min read
Business
CS Genetics Appoints Jeremy Preston, PhD, as Chief Executive Officer
CS Genetics, a privately held genomics-technology company, announced the appointment of Jeremy Preston, PhD, as Chief Executive Officer, after serving as Chief Commercial Officer for the past 14 months.
May 2, 2023
·
3 min read
Press Releases
CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody
December 23, 2024
·
5 min read
Drug Development
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
Arch Biopartners Inc. announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
June 18, 2024
·
5 min read
1 of 10,621
Next
